Samrat Remedies Limited, a active public limited company, was established on 21 August 2003 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24231MH2003PLC392453. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.07 Cr.
It upholds a compliant status. Employing 21 professional, Its leadership includes Champaklal Kantilal Parekh (Whole-Time Director), Hitesh Champak Parekh (Managing Director), Saroj Champaklal Parekh (Whole-Time Director). Past directors included Champaklal Kantilal Parekh, Saroj Champaklal Parekh, Sangeeta Hitesh Parekh. It holds no open charges and ₹8.91 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 208, 2Nd Floor, De Elmas, Pahadi Village, Sonawala Cross Lane No. 2, Goregaon East, ,, Mumbai, Maharashtra, 400063.
U24231MH2003PLC392453
392453
21 August 2003
₹1.50 Cr
₹1.07 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Samrat Remedies Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Champaklal Kantilal Parekh | Whole-Time Director | 25 Aug 2003 | Current |
| Hitesh Champak Parekh | Managing Director | 25 Aug 2003 | Current |
| Saroj Champaklal Parekh | Whole-Time Director | 16 Sep 2005 | Current |
| Sangeeta Hitesh Parekh | Whole-Time Director | 16 Sep 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jan 2012 | Past |
| Pramod Abcsdd | Director | 01 Jan 2012 | Past |
| Pramod Abcsdd | Director | 01 Jan 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Samrat Remedies Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1861.96% increase. The company also saw a substantial improvement in profitability, with a 38626.42% increase in profit. The company's net worth Soared by an impressive increase of 88.77%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Samrat Remedies had a promoter holding of 96.60% and a public holding of 3.40%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹89,050,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Aug 2008 | Others | ₹3.60 Cr | Satisfied |
| 30 Jan 2008 | The Saraswat Co-Operative Bank Limited | ₹5.55 M | Satisfied |
| 15 Apr 2006 | The Saraswat Co-Operative Bank Limited | ₹1.50 Cr | Satisfied |
| 15 Apr 2006 | The Saraswat Co-Operative Bank Limited | ₹3.25 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Samrat Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Samrat Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samrat Remedies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Samrat Remedies Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Samrat Remedies Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
A charge registered on 09 Aug 2008 via Charge ID 10133784 with Others was fully satisfied on 25 Mar 2022. was recorded as a recent event.
The activity A charge with Others of Rs. 3.60 Cr registered on 09 Aug 2008 with Charge ID 10133784 was modified on 23 Oct 2020. was completed.
The activity A charge registered on 30 Jan 2008 via Charge ID 10102043 with The Saraswat Co-Operative Bank Limited was fully satisfied on 17 Jan 2018. was completed.
Progress on A charge registered on 15 Apr 2006 via Charge ID 80017200 with The Saraswat Co-Operative Bank Limited was fully satisfied on 17 Jan 2018. was documented.
The CIN of Samrat Remedies Limited is U24231MH2003PLC392453.
Samrat Remedies Limited is headquartered at 208, 2Nd Floor, De Elmas, Pahadi Village, Sonawala Cross Lane No. 2, Goregaon East, ,, Mumbai, Maharashtra, 400063.
Samrat Remedies Limited was incorporated on 21 August 2003.
The current directors of Samrat Remedies Limited are
The primary industry of Samrat Remedies Limited is Manufacturing.
Samrat Remedies Limited is unlisted.
The authorized capital of Samrat Remedies Limited is ₹1.50 Cr, and the paid-up capital is ₹1.07 Cr.
The compliance status of Samrat Remedies Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX